To test whether NAT10 is required for brain metastasis by lung cancer, we used H2030-BrM3 cells, brain metastatic derivatives of the H2030 non–small cell lung cancer cell line harboring the KRASG12C mutation. Here, NAT10 is linked to lung carcinoma.